Last reviewed · How we verify
Salkera Emollient Foam
Salkera Emollient Foam provides topical moisturization and skin barrier support through emollient ingredients.
Salkera Emollient Foam provides topical moisturization and skin barrier support through emollient ingredients. Used for Dry skin and xerosis, Atopic dermatitis and eczema support.
At a glance
| Generic name | Salkera Emollient Foam |
|---|---|
| Sponsor | Wright State University |
| Drug class | Topical emollient |
| Modality | Small molecule |
| Therapeutic area | Dermatology |
| Phase | FDA-approved |
Mechanism of action
This is a topical foam formulation designed to hydrate and protect the skin by occluding moisture and providing emollient compounds. It is intended for use in dermatological conditions where skin barrier function is compromised or moisture retention is therapeutically beneficial.
Approved indications
- Dry skin and xerosis
- Atopic dermatitis and eczema support
Common side effects
- Local skin irritation
- Contact dermatitis
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Salkera Emollient Foam CI brief — competitive landscape report
- Salkera Emollient Foam updates RSS · CI watch RSS
- Wright State University portfolio CI